Shares of Nuformix plc (LON:NFX – Get Free Report) shot up 5.5% during mid-day trading on Friday . The company traded as high as GBX 0.18 and last traded at GBX 0.17. 322,418 shares were traded during mid-day trading, a decline of 99% from the average session volume of 35,481,805 shares. The stock had previously closed at GBX 0.17.
Nuformix Stock Up 9.1%
The business’s 50-day simple moving average is GBX 0.18 and its 200-day simple moving average is GBX 0.23. The stock has a market cap of £4.70 million, a PE ratio of -4.58 and a beta of 1.55.
Nuformix (LON:NFX – Get Free Report) last released its quarterly earnings data on Thursday, May 28th. The company reported GBX (0.02) earnings per share (EPS) for the quarter.
About Nuformix
Nuformix plc operates in the field of pharmaceutical development for treating fibrosis and oncology through drug repurposing in the United Kingdom. It offers NXP001, which has completed Phase 1 for use in oncology supportive care. The company is also developing NXP004, a novel form of Olaparib, which is in the IP generation phase for treating oncology; and NXP002 that is in pre-clinical stage for the treatment of idiopathic pulmonary fibrosis. It also has an option agreement with Oxilio Ltd. for NXP001 for oncology indications.
Featured Stories
- Five stocks we like better than Nuformix
- 3 Stocks Rallying on Micron’s Price Boost: Substance or Hype?
- Snowflake and the Snowballing Impact of its AI Flywheel
- AI’s Biggest Bottleneck Could Make These 2 Stocks Soar
- These 3 Beaten-Down Stocks Just Saw $25 Million in Insider Buying
Receive News & Ratings for Nuformix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nuformix and related companies with MarketBeat.com's FREE daily email newsletter.
